Ricardo R Fonseca

Summary

Country: Portugal

Publications

  1. ncbi Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer
    Ricardo R Fonseca
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil EPE, Lisboa, Portugal
    Am J Surg Pathol 30:1292-8. 2006
  2. ncbi HER2/neu detection by immunohistochemistry: optimization of in-house protocols
    Hugo M Lourenço
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil, Lisboa, Portugal
    Appl Immunohistochem Mol Morphol 17:151-7. 2009

Collaborators

Detail Information

Publications2

  1. ncbi Evaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancer
    Ricardo R Fonseca
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil EPE, Lisboa, Portugal
    Am J Surg Pathol 30:1292-8. 2006
    ..Therefore, despite their low incidence in MBC, expression abnormalities of ERBB2 behave, together with the pathologic stage of the tumor, as predictors of overall survival, akin to what has been reported for its female counterpart...
  2. ncbi HER2/neu detection by immunohistochemistry: optimization of in-house protocols
    Hugo M Lourenço
    Servico de Anatomia Patologica, Instituto Português de Oncologia de Lisboa de Francisco Gentil, Lisboa, Portugal
    Appl Immunohistochem Mol Morphol 17:151-7. 2009
    ..This in-house protocol for HER2 expression evaluation can be an efficient, specific, and accurate alternative to the FDA-approved kit in a more cost effective manner...